Scaling trials across sites can lock in supply risk early. Learn how biologic variability, long lead times, and multisite complexity threaten trials and how to spot warning signs fast.
- Building A Culture Of Compliance In Clinical Supply
- Global Clinical Supply Chain in Emerging Markets: Reliability, Compliance, Access
- Clinical Supply Is Not A Fix-It Function. It's A Planning Function.
- Sales & Operations Planning for Small Teams: Aligning Clinical Supply
- The Trends Shaping Clinical Trial Supply
- What 2025 FDA Warning Letters Tell Us About GMP Compliance
- Clinical Supply's Role In Driving Success In Decentralized Trials
- Phages As A Pharmaceutical: New EMA Guidance On Antimicrobial Drug Development
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Logistics, Transport Challenges Require Complex Solutions
The pandemic created additional obstacles for the clinical supply chain. Ensuring continued clinical trial operation requires an optimal management solution for clinical material supply.
-
Creating Accurate, Efficient, And Effective CDMO Project Proposals
To receive the most comprehensive project proposal possible, it is important to fill out any questionnaire as accurately and completely as possible.
-
Driving Successful Obesity Drug Development With GLP-1 Agonists
GLP-1 agonists are revolutionizing obesity treatment. Signant Health's ePRO solutions support over 30 trials, providing critical patient data and driving successful approvals.
-
Planning Your Packaging For A Seamless Transition From Clinic To Launch
Explore how clinical and commercial teams should work together for clinical supply packaging, how the COVID-19 pandemic has changed things, and what to consider when looking for a packaging partner.
-
How Direct-To-Patient Models Can Provide Clinical Supply Chains With An End-To-End Solution
Analyze the benefits and challenges of implementing direct-to-patient services in the clinical supply chain to help meet patient requirements, improve supply chain efficiency, and accelerate speed to market.
-
Benefits Of Electronic Labels: Investigational Medicinal Products
When a new therapeutic drug, medical device, vaccine, or other investigational medicinal product (IMP) is developed, learn why a label must be on its packaging that provides relevant and important information.
-
Creating A Sustainable Pharmaceutical Supply Chain
Learn how CDMOs can drive transformation in the supply chain and create a more sustainable future for the pharmaceutical manufacturing industry.
-
Development And Manufacture Of A Highly Potent OSD Product
Highly potent drug compounds require advanced containment and robust technical transfer protocols. CDMOs overcome challenges through meticulous testing, specialized tooling, and strong supplier relationships.
-
Delivering Apheresis Treatment From The USA To The UK Within 24 Hours
The goal was to perform next-day collection of temperature-sensitive tumor material for an urgent patient treatment. A flexible mitigation strategy was essential to manage short turnaround.
-
Adapting Drug Supply Strategies To Modern Study Models
Advancements like remote-access drug refrigerators and smart packaging highlight the need for patient-centric trial models that integrate virtual and site-based activities to meet diverse patient needs.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.